We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Vectura Group Plc | LSE:VEC | London | Ordinary Share | GB00BKM2MW97 | ORD 0.0271P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 164.80 | 164.80 | 165.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
10/11/2016 13:03 | Not another Grand old duke of York day, I hope, but it's looking a bit like it, a common pattern for VEC. | alexchry | |
10/11/2016 10:53 | I'm quite liking Donald Trumps administration already long may the rally continue | cap160 | |
10/11/2016 09:23 | It looks tentatively as if the share price may have formed a bottom.... in which case 160p beckons. | boadicea | |
10/11/2016 09:19 | Prosperity | tcarter66208 | |
09/11/2016 10:47 | Biotech growth up 8% | richtea1701 | |
09/11/2016 09:50 | Can't do any harm....... | soundbuy | |
09/11/2016 09:13 | Am ok went to bed thinking Trump would win I see the BBC got it wrong again most of there reporting pro Clinton, real people real votes just like EU VOTE, now we will get they didn't know what they were voting for, Cheers Happy POB | pooroldboy55 | |
09/11/2016 08:52 | Yeah, cheer up. We're gunna make Vectura great again. It's gunna be great. So great | saxula | |
09/11/2016 08:52 | It's a buy here no Clinton admin to hurt it anymore | nw99 | |
09/11/2016 08:45 | Cheer up oldboy | richtea1701 | |
09/11/2016 08:44 | Yes let's hope so .I see I was wrong about yesterday's finnish | pooroldboy55 | |
09/11/2016 07:04 | Biotech rally anyone? | richtea1701 | |
08/11/2016 13:48 | looks like yesterdays gain will soon be gone | pooroldboy55 | |
07/11/2016 19:12 | Good posts today, should we be nervous or confident? A lot of bad news of late, is it fully priced in, we seem to be consolidating at these levels so I'm holding on, but my confidence has been severely tested this year. | diesel | |
07/11/2016 16:04 | Seems to have support now lower that 130, I'd say with them pending results from trials and financial interims, itll rise hopefully, just slower than first expected..... I'm sticking for the time being | tcarter66208 | |
07/11/2016 15:28 | Unfortunately the campaigning for the mid-terms starts Thursday!It's permanent electioneering in the US! | fhmktg | |
07/11/2016 15:21 | Like your thinking Carpa - especially the win win bit. Either way think the market will be glad the circus has left town. | richtea1701 | |
07/11/2016 14:42 | It was a nasty little stop hunt at opening. IG showed 128.27 as the low. Interesting to see what happens in the next 48 hours. | richtea1701 | |
07/11/2016 14:28 | Rocketing up now ;) | richtea1701 | |
07/11/2016 13:04 | P/E of over 100 doesn't help. | fhmktg | |
07/11/2016 12:35 | a1ord53-I never looked at VEC before the merger/takeover and when SKP announced it and the share price went up, I assumed that SKP directors knew what they were doing and it was a good thing. I see that the VEC share price had fallen from a high of nearly 200 to around 150 at the start of the year but went back up to 170+ after the takeover announcement. From then it has fallen fairly steadily to around 130 today. It looks like VEC were falling out of favour prior to the merger so I'm not sure whether the fall since then is a reflection of that or the bad news over the past few months. VEC's MD described these setbacks as very frustrating, he's not the only one who's frustrated! I can understand his desire to find a ready made company to takeover and sell VEC products given that VEC are subject to the whims and wishes of big pharma, they are in litigation with GSK and Novartis are not only delaying their marketing plans for Ultibron but are running a new trial. I just hope that the litigation gets sorted out, the Novartis trial is successful and the results later this month are good. If so, I expect that we will see a big recovery in the share price so I am continuing to hold and I'm keeping my fingers crossed. | alexchry | |
07/11/2016 12:25 | Results of the study of Ultibro versus Anoro Ellipta for COPD will be available end November then the decision to go ahead in the USA will be taken.That could give us the Xmas boost we all need.After that it's the FDA decision on VR 315 versus Advair with Hikma in May 2017.Those two plus the continued growth of Flutiform numbers are the keys for the corporate strategy.Keep the faith! | fhmktg | |
07/11/2016 12:25 | failure to break resistance cause now try to break support very dangerous for share price and will cause reevaluation of Vec it looks like current valuation is to rich for city and analysts recommendations just nonsence imo | a1ord53 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions